These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9371246)

  • 1. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
    Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U
    J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists.
    Nordvall G; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U
    J Med Chem; 1996 Aug; 39(17):3269-77. PubMed ID: 8765510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Heteroaryl-substituted quinuclidin-3-ol and quinuclidin-2-ene derivatives as muscarinic antagonists. Synthesis and structure-activity relationships.
    Nilsson BM; Sundquist S; Johansson G; Nordvall G; Glas G; Nilvebrant L; Hacksell U
    J Med Chem; 1995 Feb; 38(3):473-87. PubMed ID: 7853341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinuclidin-2-ene-based muscarinic antagonists.
    Hacksell U; Nilsson BM; Nordvall G; Johansson G; Sundquist S; Nilvebrant L
    Life Sci; 1995; 56(11-12):831-6. PubMed ID: 10188782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
    Nilvebrant L
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
    Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
    J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
    Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Heteroarylquinuclidin-2-ene derivatives as muscarinic antagonists: synthesis, structure-activity relationships and molecular modelling.
    Nordvall G; Nilsson BM; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U
    Prog Brain Res; 1996; 109():141-5. PubMed ID: 9009700
    [No Abstract]   [Full Text] [Related]  

  • 9. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
    Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
    J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
    Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
    J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid gland and ileum.
    Nilvebrant L; Sparf B
    Scand J Gastroenterol Suppl; 1982; 72():69-77. PubMed ID: 6957999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
    Stevens LA; Sellers DJ; McKay NG; Chapple CR; Chess-Williams R
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):303-9. PubMed ID: 16879496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.
    Starck JP; Talaga P; Quéré L; Collart P; Christophe B; Lo Brutto P; Jadot S; Chimmanamada D; Zanda M; Wagner A; Mioskowski C; Massingham R; Guyaux M
    Bioorg Med Chem Lett; 2006 Jan; 16(2):373-7. PubMed ID: 16275087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
    Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
    J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
    Mansfield KJ; Chandran JJ; Vaux KJ; Millard RJ; Christopoulos A; Mitchelson FJ; Burcher E
    J Pharmacol Exp Ther; 2009 Mar; 328(3):893-9. PubMed ID: 19029429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors.
    Ward TR; Ferris DJ; Tilson HA; Mundy WR
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):300-7. PubMed ID: 8212012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological activity and receptor-binding characteristics of 2 beta-(2'-phenyl-2'-cyclopentyl-2'-hydroxy-ethoxy)tropane and its optical isomers.
    Gao ZG; Cui WY; Wang L; Liu CG
    Arch Int Pharmacodyn Ther; 1996; 331(2):124-35. PubMed ID: 8937624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
    J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
    Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.